CRSP
CRISPR Therapeutics AG · Healthcare
CEO Samarth Kulkarni sold $1.6M of CRISPR Therapeutics AG
Sold$1,615,160
$64.61Price
25,000Shares
−8%Stake
What CRSP did after the filing
- The stock from Fri, Sep 30 close, $65.35
- −7.7%
- S&P 500, same days
- +11.6%
Measured over 30 trading days, to the Nov 11 close.
Traded Wed, Sep 28. Filed Fri, Sep 30, 1:42 PM ET, during the session. Returns use the Sep 30 close and the Nov 11 close. Not investment advice.